Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shelter PharmaBOM:543963 +9.14%69 PB Ratio is 0.69 as of Aug. 24, 2026, which is 52% below its 10-year median of 1.45. GuruFocus rates BOM:543963 with a GF Score™ of 69/100 and a GF Value™ of ₹57.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 919 Drug Manufacturers companies, Shelter Pharma ranks better than 86.62% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-24), Shelter Pharma's share price is ₹32.00. Shelter Pharma's Book Value per Share for the quarter that ended in Mar. 2026 was ₹46.13. Hence, Shelter Pharma's PB Ratio of today is 0.69.
The historical rank and industry rank for Shelter Pharma's PB Ratio or its related term are showing as below:
BOM:543963'
s PB Ratio Range Over the Past 10 Years
Min: 0.55 Med: 1.45 Max: 5.54
Current: 0.69
During the past 7 years, Shelter Pharma's highest PB Ratio was 5.54. The lowest was 0.55. And the median was 1.45.
BOM:543963's PB Ratio is ranked better than 86.62% of 919
companies
in the Drug Manufacturers industry
Industry Median: 1.96
vs BOM:543963: 0.69
During the past 12 months, Shelter Pharma's average Book Value Per Share Growth Rate was 24.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 54.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 56.30% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Shelter Pharma was 71.00% per year. The lowest was 27.70% per year. And the median was 61.35% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shelter Pharma PB Ratio Related Terms
Shelter Pharma PB Ratio Historical Data
* Premium members only.
The historical data trend for Shelter Pharma's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Shelter Pharma's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shelter Pharma (BOM:543963) has a PB Ratio of 0.69 as of Aug. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shelter Pharma and its competitors. This is 52% below median its historical median of 1.45. Over the past decade, Shelter Pharma's PB Ratio has ranged from 0.55 to 5.54. According to the industry distribution chart, Shelter Pharma ranks #123 out of 919 companies in the Drug Manufacturers industry, placing it in the top 13.4%.
Is Shelter Pharma's PB Ratio too high?
Shelter Pharma's current PB Ratio of 0.69 is 52% below median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 5.54. The Drug Manufacturers industry median PB Ratio is 1.96. Shelter Pharma's value of 0.69 is 64.8% below this industry median. Based on the distribution chart, Shelter Pharma ranks #123 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shelter Pharma has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #123 out of 919 companies for PB Ratio. This places Shelter Pharma in the top 13% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.96. Shelter Pharma's value of 0.69 is 64.8% below this benchmark. Historically, Shelter Pharma's own PB Ratio has ranged from 0.55 to 5.54 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 1.96, Shelter Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.96, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current PB Ratio of 0.69 is 64.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current PB Ratio is 0.69, which is 52% below median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.28, compared to a current price of ₹32.00 — trading 44.1% below its estimated fair value. The current PB Ratio is 0.69, which is 52% below median its 10-year median of 1.45 and 64.8% below the Drug Manufacturers industry median of 1.96. Shelter Pharma's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current PB Ratio is 0.69 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹32.00 is trading 44.1% below its estimated GF Value™ of ₹57.28.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
PB Ratio: 0.69 (52% below median its 10-year median of 1.45)
GF Value™: ₹57.28 vs. price of ₹32.00 (44.1% below fair value)
Industry Position: 64.8% below the Drug Manufacturers median (#123 of 919)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
69GF Score
Get the complete analysis for BOM:543963
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
